Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Protease-sparing regimen
Подписчиков: 0, рейтинг: 0
Protease-sparing regimen | |
---|---|
Other names | PSR |
Specialty | virology |
Protease-sparing regimen, often abbreviated as PSR, is a method or therapy for treating people infected with HIV that involves a three-drug combination that reduces viral load below the limit of detection while saving protease inhibitors for later use. It is considered a weaker (in terms of quantity and concentration) form of HIV treatment. It has been argued that such a regimen is not as potent as giving HIV patients with the strongest drugs as soon as it is detected. Others believe that this might be considered a long-term strategy in order to reduce the amount of HIV, and in some instances have proven to be successful.
See also
External links
- "Protease Sparing Regimen in a Real Life Practice with Naive Patients: An Equal Opportunity Approach?". 13th International AIDS Conference. Durban, South Africa. July 9–14, 2000. WePeB4134. Archived from the original on 2007-09-30. Retrieved 2007-04-17.
- http://www.aids-ed.org/aidsetc?page=et-14-00-02
- http://www.medscape.com/viewarticle/418668